It is a pharma private limited company based in Patancheru, Telangana, India, established in 2021.
2021 | Patancheru, Telangana, India | ActiveApigran Pharma Private Limited, a active private limited company, was established on 22 December 2021 in Patancheru, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290TG2021PTC158179. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kruti Nishit Kadakia (Director), Lavanya Yerram (Director), Nishit Prakash Chandra Kadakia (Additional Director). It holds ₹14.55 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 5 & 6/31 Ida Phase Ii, Patancheru, Telangana, 502324.
U24290TG2021PTC158179
158179
22 December 2021
₹4.00 Cr
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Apigran Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kruti Nishit Kadakia | Director | 22 Dec 2021 | Current |
| Lavanya Yerram | Director | 22 Dec 2021 | Current |
| Nishit Prakash Chandra Kadakia | Additional Director | 01 Apr 2024 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Apigran Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Apigran Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹145,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 2022 | Others | ₹14.55 Cr | Open |
Explore comprehensive loan charge details -
Apigran Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apigran Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apigran Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Apigran Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Apigran Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Nishit Prakash Chandra Kadakia was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
A charge with Others of Rs. 14.55 Cr registered on 17 Aug 2022 with Charge ID 100607077 was modified on 10 Dec 2022. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 14.55 Cr with Charge ID 100607077 was registered on 17 Aug 2022. was completed.
Progress on Kruti Nishit Kadakia was appointed as a Director was appointed as a Director on 22 Dec 2021 & has been associated with this company since 4 years 26 days . was documented.
The CIN of Apigran Pharma Private Limited is U24290TG2021PTC158179.
Apigran Pharma Private Limited is headquartered at Plot No 5 & 6/31 Ida Phase Ii, Patancheru, Telangana, 502324.
Apigran Pharma Private Limited was incorporated on 22 December 2021.
The current directors of Apigran Pharma Private Limited are
The primary industry of Apigran Pharma Private Limited is Pharma.
Apigran Pharma Private Limited is unlisted.
The authorized capital of Apigran Pharma Private Limited is ₹4.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Apigran Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX